Ovarian stimulation and embryo quality

Reproductive BioMedicine Online

Volumn 18, Issue SUPPL. 2, 2009, Pages

  Baart, Esther B ^a,b   Macklon, Nick S ^a   Fauser, Bart J C M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Embryo quality; Ovarian stimulation; Preimplantation genetic diagnosis

Indexed keywords

ACYL COENZYME A DESATURASE; AMPHIREGULIN; CONNEXIN 43; CYCLOOXYGENASE 2; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PENTRAXIN 3; RECOMBINANT FOLLITROPIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANEUPLOIDY; ARTICLE; CELL COMMUNICATION; CHROMOSOME ANALYSIS; CUMULUS CELL; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; EMBRYONIC STRUCTURES; FERTILIZATION; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GRANULOSA CELL; HUMAN; MOLECULAR MECHANICS; NIDATION; NON INVASIVE MEASUREMENT; OOCYTE; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; POLYMERASE CHAIN REACTION; PREGNANCY RATE; PRENATAL DIAGNOSIS; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 64949106530     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60448-8     Document Type: Article

References (45)

1. Albertini DF, Sanfins A, Combelles CM 2003 Origins and manifestations of oocyte maturation competencies. Reproductive BioMedicine Online 6, 410-415.
2. Al-Inany HG, Abou-Setta AM, Aboulghar M 2007 Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reproductive BioMedicine Online 14, 640-649.
3. Assidi M, Dufort I, Ali A et al. 2008 Identification of potential markers of oocyte competence expressed in bovine cumulus cells matured with follicle-stimulating hormone and/or phorbol myristate acetate in vitro. Biology of Reproduction 79, 209-222.
4. Assou S, Anahory T, Pantesco V et al. 2006 The human cumulus-oocyte complex gene-expression profile. Human Reproduction 21, 1705-1719.
5. Baart EB, Martini E, Eijkemans MJ et al. 2007 Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Human Reproduction 22, 980-988.
6. Borm G, Mannaerts B 2000 Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Human Reproduction 15, 1490-1498.
7. Campbell BK, Scaramuzzi RJ, Webb R 1995 Control of antral follicle development and selection in sheep and cattle. Journal of Reproduction and Fertility 49 (suppl.), 335-350.
8. Cillo F, Brevini TA, Antonini S et al. 2007 Association between human oocyte developmental competence and expression levels of some cumulus genes. Reproduction 134, 645-650.
9. Cohen J, Grifo JA 2007 Multicentre trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings. Reproductive BioMedicine Online 15, 365-366.
10. Devroey P, Fauser BC 2007 Preimplantation aneuploidy screening: a research tool for now. Lancet 370, 1985-1986.
11. Eppig JJ 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122, 829-838.
12. Fauser BC, Devroey P 2005 Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in-vitro fertilization so slow? Fertility and Sterility 83, 1607-1611.
13. Fauser BC, Van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 18, 71-106.
14. Fauser BC, Devroey P, Yen SS et al. 1999 Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Human Reproduction 14, 2681-2686.
15. Feuerstein P, Cadoret V, Dalbies-Tran R et al. 2007 Gene expression in human cumulus cells: one approach to oocyte competence. Human Reproduction 22, 3069-3077.
16. Gosden RG, Bownes M 1995 Cellular and molecular aspects of oocyte development. In: Grudzinskas JG, Yovich JL (eds) Gametes - the Oocyte. Cambridge University Press, Cambridge, UK, 23-53.
17. Hamel M, Dufort I, Robert C et al. 2008 Identification of differentially expressed markers in human follicular cells associated with competent oocytes. Human Reproduction 23, 1118-1127.
18. Harper J, Sermon K, Geraedts J et al. 2008 What next for preimplantation genetic screening? Human Reproduction 23, 478-480.
19. Heijnen EMEW, Eijkemans MJC, De Klerk C et al. 2007 A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 369, 743-749.
20. Hodges CA, Ilagan A, Jennings D et al. 2002 Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation. Human Reproduction 17, 1171-1180.
21. Hohmann FP, Macklon NS, Fauser BC 2003 A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in-vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism 88, 166-173.
22. Hutt KJ, Albertini DF 2007 An oocentric view of folliculogenesis and embryogenesis. Reproductive BioMedicine Online 14, 758-764.
23. Jacob S, Moley KH 2005 Gametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies. Pediatric Research 58, 437-446.
24. Kolibianakis EM, Collins J, Tarlatzis BC et al. 2006 Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Human Reproduction Update 12, 651-671.
25. Macklon NS, Stouffer RL, Giudice LC et al. 2006 The science behind 25 years of ovarian stimulation for IVF. Endocrine Reviews 27, 170-207.
26. Macklon NS, Geraedts JP, Fauser BC 2002 Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Human Reproduction Update 8, 333-343.
27. Magli MC, Gianaroli L, Ferraretti AP et al. 2007 Embryo morphology and development are dependent on the chromosomal complement. Fertility and Sterility 87, 534-541.
28. Magli MC, Jones GM, Gras L et al. 2000 Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. Human Reproduction 15, 1781-1786.
29. Mastenbroek S, Twisk M, van Echten-Arends J et al. 2007 In-vitro fertilization with preimplantation genetic screening. New England Journal of Medicine 357, 9-17.
30. McKenzie LJ, Pangas SA, Carson SA et al. 2004 Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF. Human Reproduction 19, 2869-2874.
31. Munné S 2006 Chromosome abnormalities and their relationship to morphology and development of human embryos. Reproductive BioMedicine Online 12, 234-253.
32. Papanikolaou EG, Camus M, Kolibianakis EM et al. 2006 In-vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. New England Journal of Medicine 354, 1139-1146.
33. Russell DL, Robker RL 2007 Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Human Reproduction Update 13, 289-312.
34. Smitz J, Andersen AN, Devroey P et al. 2007 Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Human Reproduction 22, 676-687.
35. Staessen C, Platteau P, Van Assche E et al. 2004 Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Human Reproduction 19, 2849-2858.
36. Tarlatzis BC, Fauser BC, Kolibianakis EM et al. 2006 GnRH antagonists in ovarian stimulation for IVF. Human Reproduction Update 12, 333-340.
37. van Sambrink EJ, Hop WC, van Dessel TJ et al. 1995 Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertility and Sterility 64, 37-43.
38. Webb R, Campbell BK 2007 Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Society of Reproduction and Fertility Supplement 64, 141-163.
39. Webb R, Campbell BK, Garverick HA et al. 1999 Molecular mechanisms regulating follicular recruitment and selection. Journal of Reproduction and Fertility Supplement 54, 33-48.
40. Weghofer A, Munne S, Brannath W et al. 2008 The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Human Reproduction 23, 499-503.
41. Wilton L 2002 Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenatal Diagnosis 22, 512-518.
42. Wolfenson C, Groisman J, Couto AS et al. 2005 Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations. Reproductive BioMedicine Online 10, 442-454.
43. Zhang X, Jafari N, Barnes RB et al. 2005 Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality. Fertility and Sterility 83, 1169-1179
44. Ziebe S, Lundin K, Janssens R et al. 2007 Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Human Reproduction 22, 2404-2413.
45. Ziebe S, Petersen K, Lindenberg S et al. 1997 Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Human Reproduction 12, 1545-1549.